Catalyst Wire Dossier Catalyst Wire Dossier

Ciclopirox Olamine topical suspension 0.77%

ciclopirox olamine topical suspension · Padagis LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ciclopirox Olamine topical suspension 0.77%, covering 2012-12-17 to 2012-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis [NA]

See pricing